From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Resynchronization Therapy for Chronic Heart Failure?

Resynchronization devices benefited heart-failure patients who were receiving standard medical therapy.

Abnormalities of cardiac conduction associated with widening of the QRS complex are common in heart failure patients. Results of small studies have suggested that resynchronization, through pacing of both the left and right ventricle, is beneficial. In this industry-supported, double-blind, multicenter U.S. study, 453 patients with moderate-to-severe heart failure, ejection fractions of <35%, and QRS durations of 130 msec or more were randomized to biventricular pacing or to receive resynchronization devices that were not programmed (control group). In addition, all patients received standard medical therapy for heart failure. Pacemakers could not be implanted in 8% of eligible patients, and 4 patients had serious complications resulting from implantation (2 died).

At 6 months, patients in the resynchronization group had significantly greater improvement in distance walked in 6 minutes (median, 39 m vs. 10 m), functional class, quality of life, exercise duration during treadmill testing (81 sec vs. 19 sec) and ejection fraction (+4.6% vs. -0.02%) than did those in the control group. Significantly fewer patients in the resynchronization group were hospitalized (8% vs. 15%) or treated with intravenous medications for heart failure (7% vs. 15%).

Comment: These results suggest that a mechanical therapy, such as biventricular pacing, improves functional status and quality of life in patients with heart failure, depressed ejection fraction, and dyssynchrony. As an editorialist points out though, important questions remain, such as the longer-term effects of resynchronization therapy on outcome (particularly survival) and the proper role of combined resynchronization and defibrillator devices. Ongoing, large-scale trials should give us more answers.

— Kirsten E. Fleischmann, MD, MPH

Published in Journal Watch General Medicine June 21, 2002

Citation(s):

Abraham WT et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002 Jun 13; 346:1845-53.

Hare JM. Cardiac-resynchronization therapy for heart failure. N Engl J Med 2002 Jun 13; 346:1902-5.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2002. Massachusetts Medical Society. All rights reserved.